[The effect of phenobarbitol treatment on hyperbilirubinemia and albumin binding capacity in premature infants].
D001663:Bilirubin / Q000097:blood; D001724:Birth Weight; D002986:Clinical Trials as Topic; D004790:Enzyme Induction / Q000187:drug effects; D005078:Exchange Transfusion, Whole Blood; D006801:Humans; D006932:Hyperbilirubinemia / Q000517:prevention & control*; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000517:prevention & control*; D008930:Mitochondria, Liver / Q000187:drug effects; D010634:Phenobarbital / Q000008:administration & dosage / Q000627:therapeutic use*; D011485:Protein Binding / Q000187:drug effects; D012709:Serum Albumin / Q000378:metabolism
D012709:Serum Albumin; D001663:Bilirubin; D010634:Phenobarbital
Der Einfluss der Phenobarbitalbehandlung auf die Hyperbilirubinämie und die Albuminbindungskapazität bei Frühgeborenen.